Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Introduction: High-dose dexamethasone is among the standard initial therapeutic options for patients with newly diagnosed immune thrombocytopenia (ITP). Although most patients achieve initial remission, optimal first-line therapy remains a challenge due to the low rates of sustained response and the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.1207-1207
Hauptverfasser:	Zhao, Peng, An, Zhuoyu, Fu, Haixia, Liu, Daihong, Dou, Liping, Liu, Yi, Liu, Hui, Wang, Zhao, Dong, Yujun, Jing, Hongmei, Zhou, Hebing, Li, Zhen-Ling, Li, Lihong, Huang, Qiu-Sha, Wu, Jin, Wu, Yejun, Wang, Chen-Cong, Zhu, Xiaolu, Chen, Qi, He, Yun, Liu, Kaiyan, Zhang, Xiaohui
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!